MedPath

Trial of novel combined therapy between interferon and hyperlipidemia for chronic hepatitis C patients

Phase 3
Recruiting
Conditions
chronic hepatitis type C
Registration Number
JPRN-UMIN000005598
Lead Sponsor
Kyoto University Graduate School of Medicine Center for Genomic Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath